Business
Dexcom officially opens diabetes device manufacturing plant in Athenry, Co Galway
Dexcom, a US multinational that makes continuous glucose monitoring technology for people managing diabetes, has officially opened a manufacturing facility in Athenry, Co Galway. The site is the company's first manufacturing plant in Europe, the Middle East and Africa, and the firm describes it as a state-of-the-art premises and a major landmark in its investment in Ireland and the region.
Jake Leach, the company's president and CEO, said the opening was an important milestone that established Dexcom's first manufacturing presence in the region. He said expanding manufacturing capacity was central to supporting growth as the firm brings its CGM products to more people worldwide, adding that large facilities now operate across the US, Europe and Asia-Pacific.
Construction on the building started in January 2024. Dexcom had previously set out plans to create more than 1,000 jobs and invest about €300m over five years. So far almost 500 people have been employed at the site, with the remaining roles expected to be filled in the coming years. Taoiseach Micheál Martin said the opening was a strong vote of confidence in the talent of the west of Ireland.
Key points
- Dexcom has officially opened a manufacturing facility in Athenry, Co Galway.
- It is the company's first manufacturing plant in Europe, the Middle East and Africa.
- Chief executive Jake Leach said the site reinforces Dexcom's long-term commitment to Ireland.
- Almost 500 people have been employed so far, against a previous plan for more than 1,000 jobs.
- Taoiseach Micheál Martin called the opening a strong vote of confidence in the west of Ireland.
Coverage from
Topics
This story was put together automatically from the sources above. Open a source to read its original report. How nuze makes stories